PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1966 August; 59(8): 744–748.
PMCID: PMC1901134

5-Hydroxytryptamine, placental function and toxaemia of pregnancy.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (864K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • AMIN AH, CRAWFORD TB, GADDUM JH. The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. J Physiol. 1954 Dec 10;126(3):596–618. [PubMed]
  • Furgiuele AR, High JP, Horovitz ZP. Some central effects of SQ 10,643 [2'3-(-dimethlaminopropylthio) cinnamanilide hydrochloride], a potent serotonin antagonist. Arch Int Pharmacodyn Ther. 1965 May;155(1):225–235. [PubMed]
  • HUGGETT AS. Aspects of placental function. Ann N Y Acad Sci. 1959 Jan 9;75:873–888. [PubMed]
  • KLINGE E, PENTTILAE O, TISSARI A. THE CONTENT OF 5-HYDROXYTRYPTAMINE IN HUMAN UTERINE AND PLACENTAL TISSUE, AND THEIR 5-HYDROXYTRYPTOPHAN DECARBOXYLASE AND MONOAMINE OXIDASE ACTIVITIES IN NORMAL AND TOXAEMIC PREGNANCIES. Acta Obstet Gynecol Scand. 1964;43:107–114. [PubMed]
  • LINDSAY D, POULSON E, ROBSON JM. The effect of 5-hydroxytryptamine on pregnancy. J Endocrinol. 1963 Mar;26:85–96. [PubMed]
  • PANIGEL M. [Contribution to the physiology of the fetoplacental circulation. I. Study of the vasomotoricity of the arteries of the human umbilical cord]. J Physiol (Paris) 1959 Nov-Dec;51:941–969. [PubMed]
  • PEPEU G, GIARMAN NJ. Serotonin in the developing mammal. J Gen Physiol. 1962 Jan;45:575–583. [PMC free article] [PubMed]
  • PICKLES VR. The effects of 5-hydroxytryptamine on hypotonic haemolysis, and on the potassium loss from erythrocytes during cold storage. J Physiol. 1956 Nov 28;134(2):484–496. [PubMed]
  • POULSON E, BOTROS M, ROBSON JM. Effect of 5-hydroxytryptamine and iproniazid on pregnancy. Science. 1960 Apr 15;131(3407):1101–1102. [PubMed]
  • POULSON E, ROBSON JM, SULLIVAN FM. Teratogenic effect of 5-hydroxytryptamine in mice. Science. 1963 Aug 23;141(3582):717–718. [PubMed]
  • Robson JM, Sullivan FM. Analysis of actions of 5-hydroxytryptamine in pregnancy. J Physiol. 1966 Jun;184(3):717–732. [PubMed]
  • RUBIN B, PIALA JJ, BURKE JC, CRAVER BN. A NEW, POTENT AND SPECIFIC SEROTONIN INHIBITOR, (SQ 10,643) 2'-(3-DIMETHYLAMINOPROPYLTHIO) CINNAMANILIDE HYDROCHLORIDE: ANTISEROTONIN ACTIVITY ON UTERUS AND ON GASTROINTESTINAL, VASCULAR, AND RESPIRATORY SYSTEMS OF ANIMALS. Arch Int Pharmacodyn Ther. 1964 Nov 1;152:132–143. [PubMed]
  • SADOWSKY A, PFEIFER Y, SADOWSKY E, TSUR C, SULMAN FG. SEROTONIN METABOLISM IN HABITUAL ABORTION. Obstet Gynecol. 1963 Dec;22:778–780. [PubMed]
  • SENIOR JB, FAHIM I, SULLIVAN FM, ROBSON JM. POSSIBLE ROLE OF 5-HYDROXYTRYPTAMINE IN TOXAEMIA OF PREGNANCY. Lancet. 1963 Sep 14;2(7307):553–554. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press